Wells Fargo & Company MN Purchases 3,002 Shares of Ardent Health Partners, LLC (NYSE:ARDT)

Wells Fargo & Company MN increased its holdings in shares of Ardent Health Partners, LLC (NYSE:ARDT) by 52.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,704 shares of the company’s stock after purchasing an additional 3,002 shares during the quarter. Wells Fargo & Company MN’s holdings in Ardent Health Partners were worth $149,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the stock. Geode Capital Management LLC boosted its stake in shares of Ardent Health Partners by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 142,563 shares of the company’s stock worth $2,435,000 after buying an additional 2,127 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of Ardent Health Partners by 9.4% during the 4th quarter. Franklin Resources Inc. now owns 917,926 shares of the company’s stock worth $15,678,000 after acquiring an additional 78,575 shares during the last quarter. Norges Bank bought a new position in Ardent Health Partners in the 4th quarter worth $1,548,000. JPMorgan Chase & Co. grew its holdings in Ardent Health Partners by 66.8% during the fourth quarter. JPMorgan Chase & Co. now owns 13,992 shares of the company’s stock valued at $239,000 after purchasing an additional 5,602 shares during the period. Finally, Pier Capital LLC lifted its position in shares of Ardent Health Partners by 70.1% during the 4th quarter. Pier Capital LLC now owns 373,904 shares of the company’s stock valued at $6,386,000 after buying an additional 154,077 shares in the last quarter.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Morgan Stanley cut their price target on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, January 21st. Royal Bank of Canada decreased their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 4th. Stephens restated an “overweight” rating and set a $22.00 price target on shares of Ardent Health Partners in a report on Tuesday, April 1st. Mizuho reduced their price target on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 9th. Finally, Guggenheim upped their target price on shares of Ardent Health Partners from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Friday. Two research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $20.75.

Ardent Health Partners Stock Performance

ARDT opened at $14.48 on Friday. The company has a market cap of $2.07 billion and a P/E ratio of 8.88. Ardent Health Partners, LLC has a 52-week low of $11.31 and a 52-week high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The firm’s 50-day moving average price is $13.09 and its 200-day moving average price is $14.97.

Ardent Health Partners (NYSE:ARDT) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.08. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. As a group, equities analysts anticipate that Ardent Health Partners, LLC will post 1.23 EPS for the current fiscal year.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.